Big Pharma strikes back with data secrecy [Off Topic]

posted by mittyri – Russia, 2019-10-28 10:13 (639 d 11:09 ago) – Posting: # 20727
Views: 2,505

(edited by mittyri on 2019-10-28 12:59)

Hi all,

Some EMA news

If the Court of Justice upholds the view that CSRs [clinical study reports] should benefit from a general presumption of confidentiality, it would change the rules of the game. Sadly, such a move could easily take us back to a situation where disclosure of clinical trial data is the exception, instead of being the norm.

See here

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
21,590 posts in 4,513 threads, 1,531 registered users;
online 4 (0 registered, 4 guests [including 4 identified bots]).
Forum time: Wednesday 22:22 CEST (Europe/Vienna)

If a man will begin with certainties, he will end in doubts;
but if he will be content to begin with doubts,
he will end in certainties.    Francis Bacon

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5